About Matt Rightmire

This author has not yet filled in any details.
So far Matt Rightmire has created 78 blog entries.

Glaukos and Avedro Announce Definitive Acquisition Agreement

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, and Avedro, Inc. (Nasdaq: AVDR), a leading hybrid ophthalmic pharmaceutical and medical technology company focused on treating corneal disease and disorders, today announced that the companies have entered into a [...]

By |2019-08-08T08:32:45-04:00August 8th, 2019|Dartmouth Innovation, News|

Evox Therapeutics Granted Key Exosome Patents

Evox Therapeutics has been granted three key patents by the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO). These three new grants are from one of several foundational patent families held by Evox and further reinforce the Company’s leading position within exosome-mediated RNA therapeutics and targeted exosome drug delivery. Read [...]

By |2019-08-07T12:14:28-04:00August 7th, 2019|News|

Ovation.io Secures $5 Million Series A Funding to Accelerate Growth of Cloud Based Laboratory Information Systems for Clinical Informatics

Ovation.io, a next-generation clinical informatics company, today announced Series A funding of $5 million led by Madrona Venture Group with participation from new investors Borealis Ventures, Nat Turner, Zach Weinberg, and existing investors StagedotO and David Shaw. Ovation.io provides operations and intelligence software for next-generation precision diagnostic labs. Ovation will use the funding to accelerate lab deployment and expand [...]

By |2019-05-24T08:38:16-04:00May 23rd, 2019|News|

Covetrus Celebrates Launch as Newly Formed Public Company

Covetrus (NASDAQ:CVET) celebrates the combination of two unique and complementary businesses – Henry Schein Animal Health and Vets First Choice – as a newly formed company. Covetrus will leverage decades-long experience, insights, technology and global scale to empower veterinarians to enhance clinical and practice health. Read More

By |2019-02-14T10:03:47-04:00February 14th, 2019|News|

Teckro raises $25 million Series C financing

Teckro has raised a fresh round of funding to accelerate its aim of helping to bring drugs and treatments to market quicker and more efficiently. The $25 million Series C round was led by Northpond Ventures with participation from Founders Fund, Sands Capital Ventures, Bill Maris’ Section 32 venture fund, and Borealis Ventures. Read More

By |2019-02-14T09:52:57-04:00February 14th, 2019|News|